A drug used to fight eczema and to combat organ rejection among transplant patients has shown promising results in lab tests against a brain disorder called Huntington’s disease.
A drug used to fight eczema and to combat organ rejection among transplant patients has shown promising results in lab tests against a brain disorder called Huntington’s disease.
